Consequently, reduced EBP50 expression in the group of patients with oropharyngeal tumours may be a result of HR-HPV E6-mediated degradation of membrane pools of EBP50 (Fig. 3d), thereby disrupting cell polarity which is central to the control of cell proliferation and cell survival [10]. Here, NHERF1 is linked to neoplasm of oropharynx.